DCF — HURLEY MEDICAL CENTER
Enterprise Value: $-346.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-346.3M
Enterprise Value
$-115.9M
PV of Cash Flows
$-230.5M
PV of Terminal Value
$-371.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $403.4M | $-18.2M | -5.0% | $-35.2M | $-32.0M |
| Year 2 | $415.5M | $-14.5M | -4.0% | $-32.1M | $-26.6M |
| Year 3 | $427.9M | $-10.7M | -3.0% | $-28.8M | $-21.6M |
| Year 4 | $440.8M | $-8.8M | -2.0% | $-27.5M | $-18.8M |
| Year 5 | $454.0M | $-7.9M | -2.0% | $-27.2M | $-16.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-346.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$391.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.0500000006383953
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5